Kirk W. Johnson - Concepedia

Author

Kirk W. Johnson

Also Known As

K W Johnson, K. W. JOHNSON, K. W. Johnson, K.W. Johnson, KIRK W. JOHNSON, Kieran Johnson, Kirk Johnson, Kirk W Johnson, Kirk W. Johnson

168

Publications

10.1K

Citations

H-Index

150

Concepts

All Affiliations

Eli Lilly (United States)University of Colorado Boulder Epigen Biosciences (United States)MediciNova (United States)Dartmouth College

About

Kirk W. Johnson is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	46	3.4K
2	Health Sciences	10	11	896
3	Social Sciences	9	9	604
4	Engineering	4	4	235
5	Natural Sciences	1	1	51

Kirk W. Johnson

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Regulation of Wnt Signaling during Adipogenesis Christina N. Bennett, Sarah E. Ross, Kenneth Longo, Journal of Biological Chemistry	2002	739
Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo David B. Ring, Kirk W. Johnson, Erik J. Henriksen, Diabetes	2003	546
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats Annemarie Ledeboer, Brian Jekich, Evan M. Sloane, Brain Behavior and Immunity MechanobiologyInflammationCytokineAnti-inflammatoryAutoimmune Disease	2006	304
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) Mark R. Hutchinson, Susannah S. Lewis, Benjamen D. Coats, Brain Behavior and Immunity Acute Opioid AnalgesiaHealth SciencesMedicinePain MedicineOpioid Withdrawal	2008	297
Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (<i>fa</i>/<i>fa</i>) Rats Gary W. Cline, Kirk W. Johnson, Werner Regittnig, Diabetes	2002	234
Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10 Erin D. Milligan, Stephen J. Langer, Evan M. Sloane, European Journal of Neuroscience	2005	215
Potential Mechanisms for a Proinflammatory Vascular Cytokine Response to Coagulation Activation Kirk W. Johnson, Yoon Jung Choi, Els DeGroot, The Journal of Immunology Potential MechanismsImmunologyPathologyInflammationThrombosis	1998	209
Preclinical pharmacological profile of the selective 5-HT<sub>1F</sub>receptor agonist lasmiditan David L. Nelson, Lee A. Phebus, Kirk W. Johnson, Cephalalgia	2010	207
Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle Svetlana E. Nikoulina, Theodore P. Ciaraldi, Sunder Mudaliar, Diabetes	2002	198
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast Yoonsang Cho, G.V. Crichlow, Jon J. Vermeire, Proceedings of the National Academy of Sciences	2010	195

Page 1